Patrick M. Sweeney & Associates’s AbbVie ABBV Stock Holding History

Patrick M. Sweeney & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.96M	Buy	26,613 +13	+0%	+$3.33K	3.92%	4
2026 Q2	$6.69M	Buy	26,600 +65	+0.2%	+$14K	3.84%	4
2026 Q1	$5.77M	Buy	26,535 +25	+0.1%	+$5.55K	3.7%	6
2025 Q4	$6.06M	Sell	26,510 -5	-0%	-$1.14K	3.79%	5
2025 Q3	$6.14M	Buy	26,515 +30	+0.1%	+$6.11K	3.97%	5
2025 Q2	$5.01M	Buy	26,485 +1	+0%	+$186	3.45%	6
2025 Q1	$5.55M	Buy	26,484 +1	+0%	+$194	4.15%	4
2024 Q4	$4.71M	Buy	26,483 +2	+0%	+$368	3.53%	6
2024 Q3	$5.23M	Buy	26,481 +1	+0%	+$187	3.84%	4
2024 Q2	$4.54M	Buy	26,480 +101	+0.4%	+$16.7K	3.67%	7
2024 Q1	$4.8M	Buy	26,379 +2	+0%	+$345	3.95%	7
2023 Q4	$4.09M	Buy	+26,377	New	+$3.85M	3.74%	6

Other funds holding ABBV

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Patrick M. Sweeney & Associates's ABBV Position: Q3 2026 in Review

Patrick M. Sweeney & Associates increased its AbbVie (ABBV) stake by 0.05% in Q3 2026, buying an estimated $3.33K and bringing the position to 26,613 shares worth $6.96M. The position accounts for 3.92% of the portfolio, ranked #4.

Patrick M. Sweeney & Associates first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 3,450 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Patrick M. Sweeney & Associates held 26,613 shares of AbbVie worth $6.96M as of Q3 2026.
Patrick M. Sweeney & Associates bought 13 AbbVie shares in Q3 2026, an estimated $3.33K.
AbbVie made up 3.92% of Patrick M. Sweeney & Associates's portfolio in Q3 2026, its #4 holding.
Patrick M. Sweeney & Associates first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
3,450 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q3 2026, filed 22 Oct 2026.